HYNE:NASDAQHoyne Bancorp, Inc. Analysis
Data as of 2026-06-18 - not real-time
$16.62
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: HYNE is trading at its 52‑week high of $16.62, just above the 20‑day SMA ($16.13) and well above the 50‑day SMA ($15.90), indicating a short‑term bullish alignment. The 14‑day RSI is soaring at 79.6, signaling overbought conditions, while the MACD remains bullish though the histogram is thin. Fundamentals: The stock carries an astronomically high trailing PE of 415x versus an industry average of 17x, yet its price‑to‑book is below 1 (0.84), reflecting an apparent discount to book value. Revenue grew 13% YoY, but operating margins are negative and cash flow is weak, with a modest cash pile of $14.4 M against $1.4 M of debt.
Risk & valuation: Low beta (0.18) and modest 30‑day volatility (8.2%) suggest limited price swings, but the combination of extreme valuation multiples, thin profitability, and a highly concentrated regional‑bank exposure raises caution. The market’s “Extreme Greed” sentiment (FGI 88.5) may be inflating price momentum beyond fundamentals.
Risk & valuation: Low beta (0.18) and modest 30‑day volatility (8.2%) suggest limited price swings, but the combination of extreme valuation multiples, thin profitability, and a highly concentrated regional‑bank exposure raises caution. The market’s “Extreme Greed” sentiment (FGI 88.5) may be inflating price momentum beyond fundamentals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Overbought RSI suggests limited upside in the near term
- Price is at resistance with thin MACD histogram
- Low beta and modest volatility support a neutral stance
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Potential pull‑back to support around $15.58 offers entry margin
- Book‑value discount (P/B < 1) provides upside if earnings improve
- Revenue growth of ~13% indicates underlying business momentum
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent earnings weakness and negative operating cash flow
- Strong balance sheet with low debt but limited profitability
- Regional‑bank sector exposure to interest‑rate and regulatory shifts
Key Metrics & Analysis
Financial Health
Revenue Growth12.90%
Profit Margin1.76%
P/E Ratio415.5
ROE0.22%
ROA0.06%
P/B Ratio0.8
Op. Cash Flow$-481449
Industry P/E17.1
Technical Analysis
TrendBullish
RSI79.6
Support$15.58
Resistance$16.62
MA 20$16.13
MA 50$15.90
MA 200$14.91
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.18
Volatility8.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.